- Home
- FLYE vs EYEN Comparison
FLYE vs EYEN Comparison
Compare FLYE & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYE
- EYEN
- Stock Information
- Founded
- FLYE 2018
- EYEN 2014
- Country
- FLYE United States
- EYEN United States
- Employees
- FLYE N/A
- EYEN N/A
- Industry
- FLYE Aerospace
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- FLYE Industrials
- EYEN Health Care
- Exchange
- FLYE Nasdaq
- EYEN Nasdaq
- Market Cap
- FLYE 10.7M
- EYEN 9.2M
- IPO Year
- FLYE 2024
- EYEN 2018
- Fundamental
- Price
- FLYE $0.41
- EYEN $0.08
- Analyst Decision
- FLYE
- EYEN Hold
- Analyst Count
- FLYE 0
- EYEN 4
- Target Price
- FLYE N/A
- EYEN $2.00
- AVG Volume (30 Days)
- FLYE 193.5K
- EYEN 19.0M
- Earning Date
- FLYE 02-10-2025
- EYEN 11-12-2024
- Dividend Yield
- FLYE N/A
- EYEN N/A
- EPS Growth
- FLYE N/A
- EYEN N/A
- EPS
- FLYE N/A
- EYEN N/A
- Revenue
- FLYE $30,297,313.00
- EYEN $31,832.00
- Revenue This Year
- FLYE N/A
- EYEN $23,413.60
- Revenue Next Year
- FLYE N/A
- EYEN $400.98
- P/E Ratio
- FLYE N/A
- EYEN N/A
- Revenue Growth
- FLYE 14.77
- EYEN 2557.10
- 52 Week Low
- FLYE $0.40
- EYEN $0.08
- 52 Week High
- FLYE $7.62
- EYEN $2.57
- Technical
- Relative Strength Index (RSI)
- FLYE N/A
- EYEN 27.49
- Support Level
- FLYE N/A
- EYEN $0.08
- Resistance Level
- FLYE N/A
- EYEN $0.09
- Average True Range (ATR)
- FLYE 0.00
- EYEN 0.01
- MACD
- FLYE 0.00
- EYEN 0.01
- Stochastic Oscillator
- FLYE 0.00
- EYEN 13.08
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.